Covalon Technologies (COV) Stock Chart & Stock Price History → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free COV Stock Alerts C$1.10 +0.01 (+0.92%) (As of 02:45 PM ET) Add Compare Share Share ChartStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines Covalon Technologies Stock Price Performance5 Day Performance-8.33%1 Month Performance-14.06%3 Month Performance+8.91%6 Month Performance-23.61%Year-To-Date Performance+3.77%1 Year Performance-45.00% Receive COV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now COV Stock Chart for Tuesday, April, 23, 2024 COV Chart by TradingView Covalon Technologies Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/22/2024C$1.09C$1.09C$1.09C$1.09900 shsC$26.89 million04/19/2024C$1.20C$1.09-9.17%C$1.20C$1.0819,500 shsC$26.89 million04/18/2024C$1.10C$1.20+9.09%C$1.20C$1.1010,755 shsC$29.60 million04/17/2024C$1.10C$1.10C$1.10C$1.093,100 shsC$27.14 million04/16/2024C$1.10C$1.10C$1.10C$1.101,700 shsC$27.14 million04/15/2024C$1.10C$1.10C$1.17C$1.107,000 shsC$27.14 million Get the Latest News and Ratings for COV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. 04/12/2024C$1.27C$1.10-13.39%C$1.17C$1.107,000 shsC$27.14 million04/11/2024C$1.27C$1.27C$1.27C$1.252,700 shsC$31.33 million04/10/2024C$1.27C$1.27C$1.27C$1.252,700 shsC$31.33 million04/09/2024C$1.27C$1.27C$1.27C$1.252,700 shsC$31.33 million04/08/2024C$1.27C$1.27C$1.27C$1.252,700 shsC$31.33 million04/05/2024C$1.25C$1.27+1.60%C$1.27C$1.134,000 shsC$31.33 million04/04/2024C$1.24C$1.25+0.81%C$1.25C$1.251,500 shsC$30.84 million04/03/2024C$1.20C$1.24+3.33%C$1.24C$1.132,100 shsC$30.59 million04/02/2024C$1.25C$1.20-4.00%C$1.21C$1.204,800 shsC$29.60 million04/01/2024C$1.20C$1.25+4.17%C$1.25C$1.2511,000 shsC$30.84 million03/29/2024C$1.20C$1.20C$1.30C$1.206,000 shsC$29.60 million03/28/2024C$1.15C$1.20+4.35%C$1.30C$1.206,000 shsC$29.60 million03/27/2024C$1.15C$1.15C$1.20C$1.1222,600 shsC$28.37 million03/26/2024C$1.20C$1.15-4.17%C$1.20C$1.1222,600 shsC$28.37 million03/25/2024C$1.28C$1.20-6.25%C$1.20C$1.201,600 shsC$29.60 million03/22/2024C$1.27C$1.28+0.79%C$1.28C$1.28600 shsC$31.58 million03/21/2024C$1.31C$1.27-3.05%C$1.27C$1.27300 shsC$31.33 million03/20/2024C$1.32C$1.31-0.76%C$1.31C$1.312,200 shsC$32.32 million03/19/2024C$1.34C$1.32-1.49%C$1.32C$1.321,100 shsC$32.56 million03/18/2024C$1.30C$1.34+3.08%C$1.34C$1.34100 shsC$33.06 million03/15/2024C$1.39C$1.30-6.47%C$1.30C$1.30100 shsC$32.07 million03/14/2024C$1.35C$1.39+2.96%C$1.39C$1.39590 shsC$34.29 million03/13/2024C$1.35C$1.35C$1.35C$1.298,700 shsC$33.31 million03/12/2024C$1.35C$1.35C$1.35C$1.298,700 shsC$33.31 million03/11/2024C$1.25C$1.35+8.00%C$1.35C$1.298,700 shsC$33.31 million03/08/2024C$1.19C$1.25+5.04%C$1.25C$1.215,800 shsC$30.84 million03/07/2024C$1.23C$1.19-3.25%C$1.25C$1.157,300 shsC$29.36 million03/06/2024C$1.20C$1.23+2.50%C$1.23C$1.1313,300 shsC$30.34 million03/05/2024C$1.20C$1.20C$1.20C$1.114,900 shsC$29.60 million03/04/2024C$1.25C$1.20-4.00%C$1.26C$1.055,800 shsC$29.60 million03/01/2024C$1.25C$1.25C$1.26C$1.25600 shsC$30.84 million02/29/2024C$1.31C$1.25-4.58%C$1.26C$1.25600 shsC$30.84 million02/28/2024C$1.37C$1.31-4.38%C$1.37C$1.287,100 shsC$32.32 million02/27/2024C$1.37C$1.37C$1.37C$1.37100 shsC$33.80 millionThe A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself.02/26/2024C$1.45C$1.37-5.52%C$1.37C$1.37100 shsC$33.80 million02/23/2024C$1.31C$1.45+10.69%C$1.45C$1.45500 shsC$35.77 million02/22/2024C$1.31C$1.31C$1.31C$1.313,907 shsC$32.32 million02/21/2024C$1.31C$1.31C$1.33C$1.315,000 shsC$32.32 million02/20/2024C$1.39C$1.31-5.76%C$1.34C$1.3123,200 shsC$32.32 million02/19/2024C$1.39C$1.39C$1.39C$1.3312,000 shsC$34.29 million02/16/2024C$1.17C$1.39+18.80%C$1.39C$1.3312,000 shsC$34.29 million02/15/2024C$1.17C$1.17C$1.17C$1.1710,000 shsC$28.86 million02/14/2024C$1.24C$1.17-5.65%C$1.17C$1.1710,000 shsC$28.86 million02/13/2024C$1.24C$1.24C$1.24C$1.194,900 shsC$30.59 million02/12/2024C$1.19C$1.24+4.20%C$1.24C$1.194,900 shsC$30.59 million02/09/2024C$1.19C$1.19C$1.20C$1.197,300 shsC$29.36 million02/08/2024C$1.19C$1.19C$1.19C$1.19100 shsC$29.36 million02/07/2024C$1.20C$1.19-0.83%C$1.19C$1.19200 shsC$29.36 million02/06/2024C$1.18C$1.20+1.69%C$1.20C$1.20400 shsC$29.60 million02/05/2024C$1.34C$1.18-11.94%C$1.22C$1.091,050 shsC$29.11 million02/02/2024C$1.22C$1.34+9.84%C$1.34C$1.221,000 shsC$33.06 million02/01/2024C$1.26C$1.22-3.17%C$1.22C$1.223,110 shsC$30.10 million01/31/2024C$1.26C$1.26C$1.26C$1.2110,000 shsC$31.08 million01/30/2024C$1.26C$1.26C$1.26C$1.2110,000 shsC$31.08 million01/29/2024C$1.26C$1.26C$1.26C$1.2110,000 shsC$31.08 million01/26/2024C$1.07C$1.26+17.76%C$1.35C$1.2032,300 shsC$31.08 million01/25/2024C$1.07C$1.07C$1.10C$1.0110,800 shsC$26.40 million01/24/2024C$1.01C$1.07+5.94%C$1.10C$1.0110,800 shsC$26.40 million01/23/2024C$1.01C$1.01C$1.01C$1.01200 shsC$24.92 million01/22/2024C$1.01C$1.01C$1.01C$1.01200 shsC$24.92 million Related Companies: Aptose Biosciences Stock Chart Devonian Health Group Stock Chart IBEX Technologies Stock Chart Ceapro Stock Chart Sirona Biochem Stock Chart Kane Biotech Stock Chart Antibe Therapeutics Stock Chart Resverlogix Stock Chart Helix BioPharma Stock Chart Aeterna Zentaris Stock Chart Receive COV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:COV) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
